ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
ASTRAZENECA PLC ADRhedged
53.28
0.0000
成交量：
- -
成交額：
- -
市值：
159.83萬
市盈率：
- -
高：
53.28
開：
53.28
低：
53.28
收：
53.28
52周最高：
56.90
52周最低：
44.36
股本：
3.00萬
流通股本：
1.00萬
量比：
2.68
換手率：
- -
股息：
0.58
股息率：
1.08%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
阿斯利康依普隆特生鈉注射液在華上市
智通财经
·
07/09
聯合開發心臟藥物III期試驗未達主要終點 阿斯利康(AZN.US)與Ionis(IONS.US)股價暴跌
智通财经
·
07/09
道指期貨微跌不足0.1% 記憶體股盤前上升 歐股早段普遍上升 英藥廠阿斯利康挫10%
AASTOCKS
·
07/09
今日關注個股：李維斯、百事可樂、阿斯利康
投资观察
·
07/09
阿斯利康心臟病藥物臨床試驗未達終點，股價暴跌9%
环球市场播报
·
07/09
阿斯利康盤前跌8.41%，現報173.37美元
每日经济新闻
·
07/09
美股異動丨阿斯利康盤前跌8.4%，Wainua後期試驗未達主要終點
格隆汇
·
07/09
美股夜盤 | 芯片、存儲、光通信概念股拉升，康寧升逾5%、英特爾、美光科技升逾3%；阿斯利康跌超7%，新藥臨床試驗未達預期
老虎资讯综合
·
07/09
歐股阿斯利康下跌9%此前其治療神經系統疾病的藥物WAINUA晚期臨床試驗未達預期。
智通财经
·
07/09
阿斯利康股價下跌8.9%，原因是WAINUA未能達到主要終點。
智通财经
·
07/09
阿斯利康發言人表示，正與英國國家醫療服務體系及英國國家健康與臨床優化研究所持續商討，以確定解決方案，支持患者獲得優赫得。
智通财经
·
07/08
中國生物製藥分別與阿斯利康、葛蘭素史克達成重要合作
证券日报
·
07/08
慢阻肺藥物市場掀起交易熱潮，阿斯利康19億美元拿下這款中國創新藥
第一财经
·
07/08
港股異動 | 中國生物製藥(01177)早盤升逾4% 附屬與阿斯利康就TQC3721訂立獨家授權協議
智通财经
·
07/08
最高19億美元，中國生物製藥與阿斯利康達成TQC3721獨家授權合作
智通财经
·
07/08
中國生物製藥：與阿斯利康就TQC3721簽訂獨家許可協議，阿斯利康獲得TQC3721在中國境外的獨家授權，該協議可獲得2
智通财经
·
07/08
數據簡報-隨着小型企業不斷湧現，減肥藥的上市競爭日益白熱化
路透中文
·
07/08
阿斯利康(AZN)股票7月6日盤中下跌3.79%：投資者必看的核心信息
TradingKey中文
·
07/06
石藥集團盤初漲近7% 石藥集團與阿斯利康達成17.7億美元新合作
新浪港股
·
07/03
睿健醫藥宣佈完成2.6億元C+輪融資；石藥集團與阿斯利康達成17.7億美元新合作｜醫藥早參
每日经济新闻
·
07/03
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/AZNH/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1789156800000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"停牌","change":0,"latestTime":"09-11 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":44.36,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650092999","title":"阿斯利康依普隆特生鈉注射液在華上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2650092999","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650092999?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 19:42","pubTimestamp":1783597333,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443382.USD","LU2237443895.HKD","LU2456880835.USD","BK4588","BK4568","LU2089984988.USD","LU2462157665.USD","LU0058720904.USD","AZN","LU2237443465.HKD","LU0708994859.HKD","BK4007","LU2468319806.SGD","LU0289739699.SGD","LU0128525929.USD","LU0889565916.HKD","LU2236285917.USD","IE00B3T34201.USD","LU2237443549.SGD","LU0432979614.USD","LU1829250122.USD","AZNH","BK4585","IPOS","LU2237443622.USD","LU0109394709.USD","LU0320765992.SGD","LU1267930573.SGD","LU0310800379.SGD","LU2417539215.USD","LU0029864427.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650929827","title":"聯合開發心臟藥物III期試驗未達主要終點 阿斯利康(AZN.US)與Ionis(IONS.US)股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2650929827","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650929827?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 19:29","pubTimestamp":1783596558,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["III","LU0310800379.SGD","LU0320765992.SGD","LU2456880835.USD","LU1829250122.USD","LU0109394709.USD","BK4007","LU0058720904.USD","LU0128525929.USD","BK4139","IE00B3T34201.USD","AZNH","LU0889565916.HKD","LU2237443895.HKD","LU2237443978.SGD","LU2089984988.USD","LU2237443549.SGD","AZN","LU2468319806.SGD","LU2462157665.USD","BK4585","LU0289739699.SGD","IONS","LU2237443382.USD","LU0708994859.HKD","LU0432979614.USD","LU2237443622.USD","LU2237443465.HKD","LU0029864427.USD","LU2236285917.USD","BK4588","BK4134","LU1267930573.SGD","LU2417539215.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650892399","title":"道指期貨微跌不足0.1% 記憶體股盤前上升 歐股早段普遍上升 英藥廠阿斯利康挫10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650892399","media":"AASTOCKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650892399?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 18:11","pubTimestamp":1783591860,"startTime":"0","endTime":"0","summary":"亚洲主要股市今日(9日)普遍上升。南韩KOSPI盘中曾升逾4%后一度倒跌，全日收升45点或0.6%，报7,291点。日经指数结束对上两日急跌势头，全日回升924点或1.4%报67,743点。中国内地A股三大指数收升1.65%至4.49%。港股收跌169点或0.7%，报24,030点。台股跌379点或0.8%，报45,3...","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112144305039_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112144305039_s.jpg"],"rights":{"source":"aastocks_forex","url":"https://www.aastocks.com/sc/forex/news/comment.aspx?source=AAFN&id=NOW.1532601&catg=1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.aastocks.com/sc/forex/news/comment.aspx?source=AAFN&id=NOW.1532601&catg=1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_forex","symbols":["DGRO","SCHD","DXD","LU0128525929.USD","DDM","LU0289739699.SGD","UDOW","LU2468319806.SGD","DOG","GRNY","VXUS","LU0889565916.HKD","VYMI","MYMmain","FDVV","LU2237443382.USD","TOPT","DIA","LU2236285917.USD","LU1267930573.SGD","LU2237443549.SGD","LU0310800379.SGD","YMmain","DGRW","MGK","VUG","XLI","LU2462157665.USD","SDY","SCHG","SDOW","IEV","DVY","DJX","VGK","VYM","DJIA","AZN","IE00B3T34201.USD","BK4588","FDN","YMAX","FGBXmain","BK4585","AZNH","LU0708994859.HKD","LU2237443622.USD",".DJI","LU1829250122.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150820563","title":"今日關注個股：李維斯、百事可樂、阿斯利康","url":"https://stock-news.laohu8.com/highlight/detail?id=1150820563","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150820563?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 17:24","pubTimestamp":1783589097,"startTime":"0","endTime":"0","summary":"SK海力士：这家韩国芯片制造商预计将于今日为其明日在美国的上市定价，此举可能成为全球规模最大的股票发行之一。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","LU2089984988.USD","LU0708994859.HKD","LU0889565916.HKD","LU0098860793.USD","LU1929549753.HKD","IE00BBT3K403.USD","BK4504","BK4007","LU1815336091.USD","LU0058720904.USD","LU2456880835.USD","LU2417539215.USD","LU2468319806.SGD","BK4568","LU0289739699.SGD","BK4094","LU0029864427.USD","LU1244550494.USD","LU0310800379.SGD","LU1244550221.USD","LU1244550577.SGD","LU2237443978.SGD","IE000SO60NU8.SGD","AZNH","IE00BLSP4452.SGD","LU0757428866.USD","LU1829250122.USD","LU2237443622.USD","BK4177","IE000BZT7R73.USD","LU0320765646.SGD","BK4585","FTXG","ATZAF","IE000WAW04H5.SGD","LU0234572021.USD","BK4588","LU2237443895.HKD","BK4202","LU1267930573.SGD","BK4534","LU2462157665.USD","LU0320765992.SGD","PEP","BK4566","IE000MB6IJN5.SGD","IE00BN8TJ469.HKD","LU1162221912.USD","IE000F7OJYX1.SGD","AZN","LEVI","LU0109394709.USD","BK4550","BK4581","LU1894683264.USD","LU0432979614.USD","BK4533","IE00B3T34201.USD","LU2237443382.USD","LU2237443465.HKD","LU2237443549.SGD","LU0128525929.USD","LU1894683348.USD","IE00BLSP4239.USD","IE0000B7K699.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650360947","title":"阿斯利康心臟病藥物臨床試驗未達終點，股價暴跌9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650360947","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650360947?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 16:34","pubTimestamp":1783586040,"startTime":"0","endTime":"0","summary":"阿斯利康新药 Wainua 未能达成试验目标：无法降低罕见心脏病患者的死亡风险与复发性心脏急症发作概率。 阿斯利康一款心脏病新药三期临床试验未达到预设疗效终点，公司股价盘中最大跌幅达 9%。 伦敦市场最新行情显示，阿斯利康股价下跌 8.9%，或将创下 2020 年 3 月新冠疫情爆发以来最差单日表现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-09/doc-inihewtc8659764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2237443382.USD","IBBQ","LU2237443895.HKD","LU2456880835.USD","BK4588","BK4568","LU2089984988.USD","LU2462157665.USD","LU0058720904.USD","AZN","BMED","LU2237443465.HKD","LU0708994859.HKD","BK4007","LU2468319806.SGD","LU0289739699.SGD","LU0128525929.USD","LU0889565916.HKD","LU2236285917.USD","IE00B3T34201.USD","LU2237443549.SGD","LU0432979614.USD","LU1829250122.USD","AZNH","BK4585","LU2237443622.USD","LU0109394709.USD","LU0320765992.SGD","LU1267930573.SGD","LU0310800379.SGD","LU2417539215.USD","LU0029864427.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650294728","title":"阿斯利康盤前跌8.41%，現報173.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650294728","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650294728?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 16:26","pubTimestamp":1783585586,"startTime":"0","endTime":"0","summary":"阿斯利康盘前跌8.41%，现报173.37美元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607093800053797.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607093800053797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2237443382.USD","LU2237443895.HKD","UUP","LU2456880835.USD","BK4588","BK4568","LU2089984988.USD","LU2462157665.USD","LU0058720904.USD","AZN","LU2237443465.HKD","LU0708994859.HKD","BK4007","LU2468319806.SGD","LU0289739699.SGD","LU0128525929.USD","LU0889565916.HKD","LU2236285917.USD","IE00B3T34201.USD","LU2237443549.SGD","LU0432979614.USD","LU1829250122.USD","AZNH","BK4585","LU2237443622.USD","LU0109394709.USD","LU0320765992.SGD","LU1267930573.SGD","UDN","LU0310800379.SGD","LU2417539215.USD","LU0029864427.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650665942","title":"美股異動丨阿斯利康盤前跌8.4%，Wainua後期試驗未達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2650665942","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650665942?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 16:14","pubTimestamp":1783584873,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AZN","AZNH","BK4585","LU0432979614.USD","IE00B3T34201.USD","LU1829250122.USD","LU2236285917.USD","LU0289739699.SGD","LU0320765992.SGD","LU1267930573.SGD","LU0889565916.HKD","LU2237443978.SGD","LU2237443465.HKD","BK4568","LU2089984988.USD","BK4588","LU2237443622.USD","LU0128525929.USD","LU0029864427.USD","BK4007","LU0058720904.USD","LU2462157665.USD","LU2417539215.USD","LU2237443382.USD","LU2468319806.SGD","LU0109394709.USD","LU0708994859.HKD","LU2237443549.SGD","LU2237443895.HKD","LU2456880835.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110335435","title":"美股夜盤 | 芯片、存儲、光通信概念股拉升，康寧升逾5%、英特爾、美光科技升逾3%；阿斯利康跌超7%，新藥臨床試驗未達預期","url":"https://stock-news.laohu8.com/highlight/detail?id=1110335435","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110335435?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 15:18","pubTimestamp":1783581505,"startTime":"0","endTime":"0","summary":"7月9日，美股夜盘时段，芯片股拉升，英特尔、迈威尔科技涨超3%，ARM涨超2%；存储概念股走高，美光科技、西部数据涨超3%，希捷科技涨超2%，闪迪涨1.5%；光通信概念股走高，康宁涨超5%，Applied Optoelectronics、Coherent涨超3%，Credo Technology、Lumentum Holdings涨超2%；阿斯利康跌超7%，此前其治疗神经系统疾病的药物WAINUA晚期临床试验未达预期。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","LU2048586759.USD","IE0034235303.USD","LU0719512351.SGD","LU2272731600.USD","IE00B5949003.HKD","LU1316542783.SGD","LU0348723411.USD","LU2237443465.HKD","INTC","IE00BK4W5L77.USD","LU1868836757.USD","LU0683600562.USD","BK4533","LU2237443549.SGD","BK4612","HK0000304805.HKD","SMHX","IE0002270589.USD","LU2089985449.USD","IE00B19Z3581.USD","LU2471134879.HKD","VGT","SOXQ","SOXX","AZN","EMSF","BK4568","FDTX","BK4588","LU2471134796.USD","BK4553","SOXS","IE000BZT7R73.USD","LU1989764748.USD","LU2168564495.EUR","HK0000304797.USD","LU2286300806.USD","LU2456880835.USD","LU2471134952.CNY","CHPY","GLWG","LU0061475181.USD","LU0708994859.HKD","LU0157215616.USD","LU1720051017.SGD","BK4527","LU0029864427.USD","IE00B19Z3B42.SGD","CHAT","LU0154236417.USD","IE000M9KFDE8.USD","AIS","LU0056508442.USD","LU0128525929.USD","LU0320765992.SGD","SOXY","LU0274383776.USD","BK4534","LU2357305700.SGD","LU0127658192.USD","PTF","LU1861215975.USD","LU2148611432.USD","LU0238689110.USD","LU1267930573.SGD","MU","MULL","LU0149725797.USD","LU2462157665.USD","LU2089984988.USD","TRFK","LU0432979614.USD","LU1267930813.SGD","FTXL","BK4602","LU2750360997.AUD","159813","LU0096364046.USD","IE000WAW04H5.SGD","BK4148","LU2720916845.USD","ARTY","IE0000B7K699.USD","LU1323610961.USD","LU1548497426.USD","LU1868837300.USD","QQQA","SG9999001424.SGD","LU2322448791.USD","LU2290526834.HKD","SHOC","LU1803068979.SGD","BK4512","FAI","AZNH","LU2168564065.EUR","IBBQ","IE00B1XK9C88.USD","IE00B7SZLL34.SGD","LU1992135472.HKD","LU2543165471.USD","LU2168564149.EUR","CNAV","LU1914381329.SGD","BK4141","WUGI","TTEQ","LU2458330169.SGD","SIXG","BMED","LU0289739699.SGD","SOXL","LU1852331112.SGD","BK4529","LU0642271901.SGD","LU0787776722.HKD","LU0889565916.HKD","TEKX","BK4532","BK4543","LU2236285917.USD","LU2360107168.USD","IE00BKDWB100.SGD","SMH","LU0889566641.SGD","BK4575","XNTK","LU2168564222.USD","IE00BK4W5M84.HKD","LU0323591593.USD","IE000SO60NU8.SGD","LU2931357623.SGD","CHPS","GB00BDT5M118.USD","IE000MB6IJN5.SGD","LU2054465674.USD","BK4605","IE000F7OJYX1.SGD","LU2102340556.USD","CGGO","DRIV","PSI","IE0009356076.USD","IE00B3T34201.USD","LU2473716301.USD","BAI","IE00BFMHRM44.USD","LU2168563687.JPY","LU1366333091.USD","AIQ","LU1868837136.USD","LU2417539215.USD","LU0109394709.USD","LU2360106780.USD","USXF","EFIV","LU1989764664.SGD","LU1829250122.USD","LU0792757196.USD","BK4007","XSD","LU0097036916.USD","IXN","LU0109392836.USD","FTEC","LU2764263203.CNY","LU2272731865.HKD","LU1804176565.USD","LU2468319806.SGD","LU2272731782.SGD","MUD","USD","BK4535","IE00BJLML261.HKD","BK4554","LU2237443382.USD","LU2322448957.HKD","LU0889565833.HKD","LU2237443895.HKD","FXL","LU0310800379.SGD","BK4550","LU0058720904.USD","LU0203347892.USD","MUU","IETC","BK4579","LU0082616367.USD","LU2471134523.USD","LU2357627491.SGD","RULE","IE00BWXC8680.SGD","SSG","LU0321505868.SGD","LU1861220033.SGD","LU2750360641.GBP","XLK","BK4566","LU2237443978.SGD","LU0321505439.SGD","LU0203345920.USD","JGRO","LU2764263039.SGD","LU2250418816.HKD","LU0859254822.USD","LU2265009873.SGD","BK4515","LEGR","LU0081259029.USD","LU2764262908.HKD","WLDR","INTW","BK4585","LU1720051108.HKD","LU1868836914.USD","GLW","EGGY","AIFD","LINT","LU2237443622.USD","LU1992135399.USD","LU2458330243.SGD","LU2211815571.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650419989","title":"歐股阿斯利康下跌9%此前其治療神經系統疾病的藥物WAINUA晚期臨床試驗未達預期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650419989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650419989?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 15:12","pubTimestamp":1783581128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0889565916.HKD","BK4007","LU2462157665.USD","VGK","LU0320765992.SGD","LU2237443465.HKD","BK4568","IE00B3T34201.USD","BMED","IBBQ","LU0289739699.SGD","AZNH","LU0128525929.USD","AZN","VXUS","LU1829250122.USD","LU2456880835.USD","LU2237443622.USD","IEV","LU2237443978.SGD","LU2236285917.USD","LU0109394709.USD","LU0310800379.SGD","LU0708994859.HKD","LU2237443895.HKD","LU1267930573.SGD","BK4585","BK4588","LU2089984988.USD","LU2468319806.SGD","LU0029864427.USD","LU0058720904.USD","LU2237443382.USD","LU2237443549.SGD","LU0432979614.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650416399","title":"阿斯利康股價下跌8.9%，原因是WAINUA未能達到主要終點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650416399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650416399?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 15:06","pubTimestamp":1783580794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443622.USD","LU0310800379.SGD","LU0708994859.HKD","BK4585","LU2456880835.USD","LU2462157665.USD","LU2237443895.HKD","LU2236285917.USD","LU2417539215.USD","IE00B3T34201.USD","LU0320765992.SGD","BK4007","LU0432979614.USD","LU0889565916.HKD","BK4568","LU2089984988.USD","LU1829250122.USD","BK4588","LU2237443549.SGD","LU0029864427.USD","LU2237443978.SGD","LU0109394709.USD","LU2237443382.USD","LU2237443465.HKD","AZNH","LU1267930573.SGD","LU0058720904.USD","LU0289739699.SGD","AZN","LU0128525929.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649993596","title":"阿斯利康發言人表示，正與英國國家醫療服務體系及英國國家健康與臨床優化研究所持續商討，以確定解決方案，支持患者獲得優赫得。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649993596","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649993596?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 19:40","pubTimestamp":1783510837,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","LU0289739699.SGD","LU0310800379.SGD","LU0029864427.USD","LU2237443978.SGD","LU0889565916.HKD","LU2089984988.USD","LU0708994859.HKD","LU2456880835.USD","LU0432979614.USD","LU2468319806.SGD","LU2462157665.USD","LU2237443465.HKD","LU2237443622.USD","BK4007","LU1267930573.SGD","BK4568","BK4588","LU2237443895.HKD","IE00B3T34201.USD","AZN","BK4585","LU0058720904.USD","LU0109394709.USD","AZNH","LU0128525929.USD","LU0320765992.SGD","LU2237443549.SGD","LU2236285917.USD","LU2237443382.USD","LU2417539215.USD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969580","title":"中國生物製藥分別與阿斯利康、葛蘭素史克達成重要合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969580","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649969580?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 15:55","pubTimestamp":1783497300,"startTime":"0","endTime":"0","summary":"7月8日，中国生物制药有限公司（以下简称“中国生物制药”）公告称，将自主研发的慢性阻塞性肺疾病（COPD）创新药TQC3721（PDE3/4抑制剂）海外权益以总额最高19亿美元授权给阿斯利康，创下近三年中国呼吸领域单产品交易额之最；同日，中国生物制药还宣布将进一步深化与葛兰素史克（GSK）的战略合作，获得GSK两款全球重磅呼吸创新药在中国内地的独家商业化权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607083798367659.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798367659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0128525929.USD","AZN","IE00BZ08YT58.USD","LU1267930573.SGD","LU0320765992.SGD","BK1589","LU2237443978.SGD","BK4007","IE00BZ08YR35.GBP","01177","LU2236285917.USD","LU2237443622.USD","LU0889565916.HKD","AZNH","LU2089984988.USD","BK1515","BK4585","LU0109394709.USD","LU2456880835.USD","LU2468319806.SGD","LU2237443382.USD","LU0310800379.SGD","LU2237443549.SGD","LU2417539215.USD","LU2462157665.USD","GSK.UK","GSK","LU0289739699.SGD","LU0432979614.USD","LU0029864427.USD","BK4532","BK1191","LU0058720904.USD","BK1521","IE00BZ08YS42.EUR","BK4568","IE00B3T34201.USD","LU0708994859.HKD","LU2237443895.HKD","HK0000165453.HKD","BK4588","GSKH","LU2237443465.HKD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649500419","title":"慢阻肺藥物市場掀起交易熱潮，阿斯利康19億美元拿下這款中國創新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2649500419","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649500419?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 13:42","pubTimestamp":1783489327,"startTime":"0","endTime":"0","summary":"继海思科之后，又有一家国产药企的慢性阻塞性肺疾病（COPD，下称慢阻肺）创新药管线达成对外授权交易。7月8日上午，中国生物制药（01177.HK）发布公告称，公司将TQC3721（PDE3/4抑制剂）海外权益以总额最高19亿美元授权给阿斯利康。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607083798231670.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798231670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B3T34201.USD","LU0128525929.USD","LU2237443978.SGD","LU2237443895.HKD","BK4585","LU1267930573.SGD","LU0889565916.HKD","LU2089984988.USD","AZNH","LU0708994859.HKD","LU2237443382.USD","KURE","LU0320765992.SGD","LU2237443465.HKD","LU0289739699.SGD","LU2456880835.USD","LU2468319806.SGD","BK4568","LU2236285917.USD","BK4588","LU2462157665.USD","LU2417539215.USD","LU2237443622.USD","LU0432979614.USD","LU0058720904.USD","LU0310800379.SGD","BK4007","LU1829250122.USD","LU0029864427.USD","AZN","LU0109394709.USD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649464959","title":"港股異動 | 中國生物製藥(01177)早盤升逾4% 附屬與阿斯利康就TQC3721訂立獨家授權協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2649464959","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649464959?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 09:33","pubTimestamp":1783474437,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国生物制药早盘涨超4%，截至发稿，涨3.94%，报5.01元，成交额8286.17万港元。消息面上，7月8日，中国生物制药发布公告，集团附属公司正大天晴药业集团股份有限公司已与阿斯利康就集团自主研发的PDE3/4抑制剂订立独家授权协议。根据协议条款，集团将授予阿斯利康在中国以外地区开发、生产及商业化TQC3721的独家许可。阿斯利康还将获得TQC3721特定开发方案的全球独家许可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0289739699.SGD","01177","IE00BZ08YT58.USD","BK1521","LU2456880835.USD","BK1191","LU2237443549.SGD","LU1829250122.USD","KCAI","LU0029864427.USD","BK1515","LU0128525929.USD","AZN","BK1589","LU2468319806.SGD","LU2237443895.HKD","LU2237443465.HKD","LU2089984988.USD","LU1267930573.SGD","LU0320765992.SGD","LU2237443382.USD","LU2236285917.USD","LU0889565916.HKD","LU2462157665.USD","VXUS","HK0000165453.HKD","LU0109394709.USD","LU0708994859.HKD","LU2237443978.SGD","LU2237443622.USD","AZNH","BK4007","LU0310800379.SGD","LU0432979614.USD","BK4585","BK4568","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","LU2417539215.USD","LU0058720904.USD","IE00B3T34201.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649558469","title":"最高19億美元，中國生物製藥與阿斯利康達成TQC3721獨家授權合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2649558469","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649558469?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 07:46","pubTimestamp":1783467993,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443895.HKD","LU2089984988.USD","LU2468319806.SGD","LU1267930573.SGD","LU0058720904.USD","LU2456880835.USD","IE00B3T34201.USD","AZN","LU0320765992.SGD","LU2236285917.USD","LU0029864427.USD","LU2462157665.USD","LU0128525929.USD","LU1829250122.USD","LU2417539215.USD","LU0109394709.USD","LU0310800379.SGD","LU0432979614.USD","LU0889565916.HKD","LU2237443465.HKD","AZNH","LU2237443622.USD","BK4585","LU0289739699.SGD","LU2237443978.SGD","LU2237443549.SGD","BK4568","BK4588","LU2237443382.USD","LU0708994859.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649958069","title":"中國生物製藥：與阿斯利康就TQC3721簽訂獨家許可協議，阿斯利康獲得TQC3721在中國境外的獨家授權，該協議可獲得2","url":"https://stock-news.laohu8.com/highlight/detail?id=2649958069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649958069?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 06:06","pubTimestamp":1783461965,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","LU0320765992.SGD","LU0128525929.USD","LU0289739699.SGD","LU2237443465.HKD","LU2468319806.SGD","LU0889565916.HKD","LU2237443382.USD","LU2236285917.USD","LU2237443895.HKD","LU1267930573.SGD","LU2237443549.SGD","LU0310800379.SGD","LU0058720904.USD","LU2462157665.USD","LU2089984988.USD","LU0432979614.USD","LU2237443978.SGD","AZN","BK4568","IE00B3T34201.USD","BK4588","LU2456880835.USD","BK4585","AZNH","LU2417539215.USD","LU0109394709.USD","LU0708994859.HKD","LU2237443622.USD","LU1829250122.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649939231","title":"數據簡報-隨着小型企業不斷湧現，減肥藥的上市競爭日益白熱化","url":"https://stock-news.laohu8.com/highlight/detail?id=2649939231","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649939231?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 00:13","pubTimestamp":1783440834,"startTime":"0","endTime":"0","summary":"数据简报-随着小型企业不断涌现，减肥药的上市竞争日益白热化在第1、2和25段中补充了Kailera Therapeutics公司肥胖症药物的详细信息路透7月7日-凯莱拉制药的KLRA.O口服减肥药在中国开展的一项晚期临床试验中，帮助患者在第44周时减重 ，最高可达体重的10.9%。这两种药物目前均处于临床前试验阶段。华东制药中国华东制药公司的口服减肥候选药物HDM1002，在中国针对超重或肥胖受试者进行的一项早期研究中，使体重最多减少了6.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T4391IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0029864427.USD","LU1066051225.USD","LU0354030511.USD","BK1574","LU1989772923.USD","LU1989772840.SGD","LU0882574139.USD","LU0321505868.SGD","ILDR","LU0320765489.SGD","THNR","IE00BZ1G4Q59.USD","IE00BK4W5M84.HKD","LU1366192091.USD","LU0109391861.USD","SGXZ51526630.SGD","LU1323610961.USD","SG9999017495.SGD","LU0265550946.USD","LU1037948541.HKD","LU1116320737.USD","LU2108987350.USD","LU1066051811.HKD","SG9999014898.SGD","LU0225771236.USD","LU2417539215.USD","LU1037948897.HKD","NVOX","LU0786609619.USD","MEDI","LU2746668461.USD","LU0964807845.USD","IE00BFSS7M15.SGD","LU0417517546.SGD","LLYX","LLYZ","JDOC","ELIS","LU0320765992.SGD","IE00BKVL7J92.USD","BK1583","LU2237443895.HKD","LU0114720955.EUR","LU2125154778.USD","LU2097828557.USD","LU0672654240.SGD","LU0203345920.USD","LU0130517989.USD","LU0203202063.USD","LU2111349929.HKD","LU1069347547.HKD","BK1191","LU1868837300.USD","LU2602419157.SGD","BK4585","LU2097828714.EUR","IE00B4R5TH58.HKD","IE00BJLML261.HKD","LU1145028129.USD","BK4007","LU2023250843.SGD","LU2089283258.USD","LU1066053197.SGD","LU1929549753.HKD","LU1267930573.SGD","LU0256863811.USD","IE00BSNM7G36.USD","LU2237443978.SGD","PPH","BK4588","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","BK4592","LU2097828805.USD","SG9999015341.SGD","LU0502904849.HKD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0683600562.USD","BK4568","LU2456880835.USD","LU0820562030.AUD","HK0000165453.HKD","LU2023251221.USD","XLV","LU1868836757.USD","BMED","LU1934455194.USD","IE00BFTCPJ56.SGD","LU2360106947.USD","LU1941712264.USD","SG9999018857.SGD","IXJ","LU2168564149.EUR","IE00BWXC8680.SGD","LU0210536198.USD","LU1127390331.HKD","LU1066051498.USD","BK4599","CURE","SG9999001176.USD","LU0823416689.USD","VHT","SG9999015952.SGD","01672","LU1057294990.SGD","LU1064131342.USD","LU0316494557.USD","SG9999002232.USD","LU1934455277.USD","LU2112291526.USD","LU1035773651.USD","LU1974910355.USD","IE0009355771.USD","LU0965509283.SGD","SGXZ99366536.SGD","LU2462157665.USD","03692","SG9999015978.USD","BK4581","BK4139","LU2097828474.EUR","BK4533","LU2361045086.USD","IE00BLSP4239.USD","LU2461242641.AUD","LU0225284248.USD","LU0211331839.USD","NVOH","LU0096364046.USD","GB00BDT5M118.USD","LLY","IE00B775H168.HKD","LU0820561818.USD","LU1116320901.HKD","LU0980610538.SGD","AZN","LU2236285917.USD","LU2361044865.SGD","HRTS","IE00BJJMRX11.SGD","LU0130102774.USD","SG9999014567.USD","LU2491050154.USD","LU1923622614.USD","LU0094547139.USD","IE00BKDWB100.SGD","LU0385154629.USD","LU0882574055.USD","LU2552382215.SGD","ELIL","LU2237443622.USD","LU1720051108.HKD","LU1969619763.USD","LU0208291251.USD","LU0133085943.USD","LU0098860793.USD","LU1934455863.HKD","LU0455707207.USD","LU2471134952.CNY","OZEM","LU0787776722.HKD","LU0708994859.HKD","LU2491050071.SGD","LU0158827948.USD","LU1720051017.SGD","SG9999014906.USD","LU0154236417.USD","SG9999014914.USD","LU0256863902.USD","LU0345770308.USD","LU1280957306.USD","GPCR","LU1093756325.SGD","LU1585245621.USD","LU2471134523.USD","LU1983299246.USD","MEDX","IYH","LU0943347566.SGD","LU0648001328.SGD","LU0006306889.USD","IHE","LU0823434583.USD","LU0985320562.USD","LU1917777945.USD","LU2087625088.SGD","LU2756315664.SGD","IE00BBT3K403.USD","AGNG","LU1291159041.SGD","PJP","IE00B3T34201.USD","LU1069344957.HKD","SG9999013999.USD","LU2471134879.HKD","RXL","IE0004445239.USD","LU1699723380.USD","BK4516","LU1201861249.SGD","IE00B19Z3B42.SGD","LU1548497426.USD","LU2271345857.HKD","LU1712237335.SGD","IE00BJT1NW94.SGD","BK4550","LU0198837287.USD","LU0289739699.SGD","LU0820561909.HKD","LU2089984988.USD","LU0310800379.SGD","LU0097036916.USD","LU0889565916.HKD","LU0070302665.USD","BK1515","LU1883839398.USD","LU0471298777.SGD","GDOC","LU0345770993.USD","LU2237443382.USD","LU2750360997.AUD","LU1629891620.HKD","LU2028103732.USD","LU2552382132.HKD","LU0861579265.USD","MRK","VKTX","LU0868494617.USD","PFE","LU0689472784.USD","LU2242644610.SGD","LU2023250504.SGD","LU2552382058.USD","LU2125909593.SGD","LU2324357040.USD","LU0234572021.USD","LU1814569148.SGD","SG9999001176.SGD","LU0306807586.USD","LU1267930730.SGD","BK1589","KURE","IE00BN29S564.USD","LU0942090050.USD","LU0122379950.USD","LU2896262040.SGD","LU0823434740.USD","CANC","IE00B4JS1V06.HKD","FHLC","LU1093756168.USD","LU2237443549.SGD","LU0965509101.SGD","LU0203347892.USD","LU0306806265.USD","LU2063271972.USD","LU2596442595.SGD","LU0354030438.USD","SG9999015945.SGD","LU1829250122.USD","LU2168564222.USD","LU0321505439.SGD","LU2328871848.SGD","LU1623119135.USD","IE00BJJMRY28.SGD","IE00B7KXQ091.USD","LU1868837136.USD","LU1023059063.AUD","LU2491049909.HKD","AZNH","LU2125154935.USD","SG9999002224.SGD","LU2023250330.USD","LU0061475181.USD","KLRA","LU0708995401.HKD","LU0868494708.USD","SG9999011175.SGD","SG9999014880.SGD","LU1035775433.USD","PAWZ","LU0640476718.USD","BK1161","IE00BLSP4452.SGD","IE0002270589.USD","IE0005OL40V9.USD","LU2237443465.HKD","SG9999014542.SGD","SG9999003800.SGD","WDNA","LU1430594728.SGD","BK4534","LLII","IE00BK4W5L77.USD","LU2361044949.HKD","LU2468319806.SGD","SGXZ81514606.USD","IE00B1BXHZ80.USD","LU0859254822.USD","LU2211815571.USD","LU2433249047.HKD","LU0238689110.USD","LU0985481810.HKD","IE0002141913.USD","LU1894683348.USD","LU0353189680.USD","IE0001KFT4U8.USD","LU1061106388.HKD","LU1988902786.USD","LU0158827781.USD","LU0432979614.USD","LU2106854487.HKD","IE0004445015.USD","LU0477156953.USD","SG9999014559.SGD","SGXZ31699556.SGD","LU0106261372.USD","LU2360032135.SGD","IE00B1XK9C88.USD","LU1941712348.USD","LU2750360641.GBP","IE00BKPKM429.USD","01801","BK4532","LU1894683264.USD","LU2357305700.SGD","LU1551013342.USD","LU1989771016.USD","SG9999014575.USD","LU1571399168.USD","SG9999001440.SGD","LU0353189763.USD","LU2213496289.HKD","LU2471134796.USD","LU1868836914.USD","LU0965509010.AUD","LU0466842654.USD","LU0471298694.HKD","LU1804176565.USD","SG9999015358.SGD","LU2168563687.JPY","LU2265009873.SGD","LU2357627491.SGD","LU0320765646.SGD","LU2089284900.SGD","LU0128525929.USD","LU2488822045.USD","IE00BFSS8Q28.SGD","LU0323591593.USD","LU1232071149.USD","LU0079474960.USD","LU2168564065.EUR","FTXH","IE00B2B36J28.USD","LU0320765059.SGD","LU2097828631.EUR","LU0265550359.USD","BK4559","IE00BN8TJ469.HKD","LU2756315318.SGD","LU0225283273.USD","LU2746668974.SGD","LU0203201768.USD","LU0109394709.USD","LU2264538146.SGD","LU0170899867.USD","SG9999018865.SGD","LU2237438978.USD","LU1551013425.SGD","SG9999015986.USD","LU0965508806.USD","LU1162221912.USD","LU2168564495.EUR","LU0266013472.USD","LU1868836591.USD","NVO","LU2125909247.SGD","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649620708","title":"阿斯利康(AZN)股票7月6日盤中下跌3.79%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2649620708","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649620708?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 23:15","pubTimestamp":1783350932,"startTime":"0","endTime":"0","summary":"• 阿斯利康与石药集团达成合作，交易总额高达17.7亿美元。\n• 受获利回吐、盈利预期修正以及监管管线不确定性影响，股价出现下跌。\n• Enhertu 获欧盟委员会批准用于治疗 HER2 阳性转移性实体瘤。","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262013535-market-movers-azn-20260706","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1829250122.USD","LU2456880835.USD","LU0432979614.USD","LU2237443895.HKD","LU0310800379.SGD","LU1267930573.SGD","LU0320765992.SGD","LU2236285917.USD","BK4568","LU0058720904.USD","LU2237443382.USD","LU2237443549.SGD","LU0109394709.USD","AZN","LU0708994859.HKD","LU2089984988.USD","LU2417539215.USD","LU2468319806.SGD","LU0029864427.USD","IE00B3T34201.USD","LU2237443978.SGD","BK4585","LU2237443465.HKD","AZNH","LU2237443622.USD","BK4588","LU0289739699.SGD","BK4007","LU2462157665.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648321696","title":"石藥集團盤初漲近7% 石藥集團與阿斯利康達成17.7億美元新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2648321696","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648321696?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 09:41","pubTimestamp":1783042860,"startTime":"0","endTime":"0","summary":" 石药集团早盘涨近7%，截至发稿，股价上涨4.64%，现报7.90港元，成交额2.37亿港元。 石药集团宣布，与阿斯利康达成小核酸药物合作。 根据该协议的条款，石药集团与阿斯利康将针对两个靶点共同发现和开发具备治疗肾脏疾病多种适应症潜力的临床前候选药物。石药集团将保留其中一个 PCC 在中国境内开发、生产和商业化的全部权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-03/doc-inifntfa5634037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2089984988.USD","LU2237443465.HKD","HK0000165453.HKD","IE00B031HY20.USD","LU0029864427.USD","LU1951186391.HKD","IE00B3T34201.USD","LU1829250122.USD","LU1152091168.USD","LU0289739699.SGD","BK4585","LU0314109678.HKD","IE00B5MMRT66.SGD","LU0310800379.SGD","SG9999004220.SGD","IE0008368742.USD","LU0072913022.USD","BK1521","AZNH","LU1226288170.HKD","IE00BZ08YR35.GBP","LU1152091754.HKD","LU0315179316.USD","BK4588","LU1328277881.USD","LU0432979614.USD","LU1226288253.USD","IE00BZ08YS42.EUR","01093","LU2237443978.SGD","BK4568","LU0880133367.SGD","LU1813983027.USD","LU1993786604.SGD","BK1191","AZN","LU0889565916.HKD","LU0708994859.HKD","LU1807302812.USD","LU2236285917.USD","LU1226287792.SGD","LU2462157665.USD","LU0501845795.SGD","LU0128525929.USD","LU2456880835.USD","LU0109394709.USD","LU0058720904.USD","LU0326950275.SGD","LU2237443382.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648663946","title":"睿健醫藥宣佈完成2.6億元C+輪融資；石藥集團與阿斯利康達成17.7億美元新合作｜醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2648663946","media":"每日经济新闻","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648663946?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 07:02","pubTimestamp":1783033372,"startTime":"0","endTime":"0","summary":"丨2026年7月3日星期五丨NO.1睿健医药宣布完成2.6亿元C+轮融资7月2日，睿健医药宣布完成2.6亿元人民币C+轮融资。本轮融资由成都科创投领投，中信建投资本、锡创投等机构共同投资。睿健医药已于2026年6月初完成2.1亿元人民币融资，公司聚焦帕金森病、视网膜退行性疾病及代谢功能衰退等方向，多条管线已在中国和美国同步推进临床开发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607033792373676.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607033792373676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2236285917.USD","LU2039709279.SGD","AZNH","LU2468319806.SGD","HK0000165453.HKD","BK4588","IE0008369823.USD","IE00B3T34201.USD","LU0320765992.SGD","IE00BZ08YT58.USD","AZN","LU1993786604.SGD","LU2456880835.USD","IE0008368742.USD","LU1267930573.SGD","LU0880133367.SGD","BK4585","LU2237443895.HKD","LU1807302812.USD","LU0310800379.SGD","LU2237443549.SGD","BK1191","IE00B543WZ88.USD","LU2417539215.USD","IE00BZ08YS42.EUR","LU0432979614.USD","LU0314109678.HKD","LU1226287792.SGD","LU0109394709.USD","09939","LU0067412154.USD","LU1152091168.USD","LU1226288253.USD","LU1960683339.HKD","01093","LU2089984988.USD","LU0128525929.USD","159938","LU0326950275.SGD","LU0315179316.USD","LU0889565916.HKD","LU0029864427.USD","LU0708994859.HKD","LU0501845795.SGD","LU1813983027.USD","LU1226288170.HKD","LU1951186391.HKD","SG9999004220.SGD","BK4007","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":6,"totalSize":162,"code":"91000000","status":"200"}]}}